# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-24-000818
Filing Date
2024-03-05
Accepted
2024-03-05 16:06:21
Documents
81
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 20-F | zk2431047.htm iXBRL | 20-F | 2454184
2 | EXHIBIT 2.1 | exhibit_2-1.htm | EX-2.1 | 36203
3 | EXHIBIT 4.11 | exhibit_4-11.htm | EX-4.11 | 641876
4 | EXHIBIT 8.1 | exhibit_8-1.htm | EX-8.1 | 2062
5 | EXHIBIT 12.1 | exhibit_12-1.htm | EX-12.1 | 7548
6 | EXHIBIT 12.2 | exhibit_12-2.htm | EX-12.2 | 7442
7 | EXHIBIT 13.1 | exhibit_13-1.htm | EX-13.1 | 4053
8 | EXHIBIT 15.1 | exhibit_15-1.htm | EX-15.1 | 3229
9 | EXHIBIT 97.1 | exhibit_97-1.htm | EX-97.1 | 31207
15 | GRAPHIC | image00001.jpg | GRAPHIC | 83565
16 | GRAPHIC | image1.jpg | GRAPHIC | 103045
17 | GRAPHIC | image0.jpg | GRAPHIC | 237185
| Complete submission text file | 0001178913-24-000818.txt |  | 9910712

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL CALCULATION FILE | cgen-20231231_cal.xml | EX-101.CAL | 52198
11 | XBRL DEFINITION FILE | cgen-20231231_def.xml | EX-101.DEF | 159498
12 | XBRL LABEL FILE | cgen-20231231_lab.xml | EX-101.LAB | 555435
13 | XBRL PRESENTATION FILE | cgen-20231231_pre.xml | EX-101.PRE | 296540
14 | XBRL SCHEMA FILE | cgen-20231231.xsd | EX-101.SCH | 54863
83 | EXTRACTED XBRL INSTANCE DOCUMENT | zk2431047_htm.xml | XML | 1315000

Mailing Address 26 HAROKMIM STREET BUILDING D HOLON L3 5885849
Business Address 26 HAROKMIM STREET BUILDING D HOLON L3 5885849 011-972-3-765-8585
COMPUGEN LTD (Filer) CIK: 0001119774 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-30902 | Film No.: 24720300
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)